Karen M. Nichols

Karen M. Nichols, Esq. has a wealth of experience in regulatory affairs and quality, spanning across various companies in the cell and genetic therapies industry. Currently serving as the Vice President of Regulatory CMC and Quality at Vertex Cell and Genetic Therapies, Karen has held significant leadership positions at companies such as Magenta Therapeutics, Bandit Enterprises, Inc., NantKwest, Inc., and many others. With an educational background in law and biology, Karen has a strong foundation to excel in their role.